The neuromuscular effects of 0.6 mg kg-1 rocuronium in elderly and young adults with or without renal failure

European Journal of Anaesthesiology

Volumn 25, Issue 11, 2008, Pages 940-946

  Kocabas, S ^a,b   Yedicocuklu, D ^a   Askar, F Z ^a  

^a EGE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Aged; Kidney failure chronic; Neuromuscular non depolarizer agents; Pharmacodynamics

Indexed keywords

PROPOFOL; ROCURONIUM;

ADULT; AGED; AGING; ANESTHETIC RECOVERY; ARTERIOVENOUS SHUNT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE KIDNEY FUNCTION RELATION; FEMALE; GENERAL ANESTHESIA; HUMAN; KIDNEY FAILURE; MALE; NEUROMUSCULAR BLOCKING; VASCULAR ACCESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANDROSTANOLS; ANESTHETICS, INTRAVENOUS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PROPOFOL; YOUNG ADULT;

EID: 53549087241     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021508004717     Document Type: Article

References (31)

1. Sparr HJ, Beaufort TM, Fuchs-Buder T. Newer neuromuscular blocking agents. How do they compare with established agents? Drugs 2001; 61: 919-942.
2. McCourt KC, Salmela L, Mirakhur RK et al. Comparison of rocuronium and suxamethonium for use during rapid sequence induction of anaesthesia. Anaesthesia 1998; 53: 867-871.
3. Proost JH, Eriksson LI, Mirakhur RK, Roest G, Wierda JMKH. Urinary, biliary and faecal excretion of rocuronium in humans. Br J Anaesth 2000; 85: 717-723.
4. Wierda JMKH, Kleef UW, Lambalk LM, Kloppenburg WD, Agoston S. The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl. Can J Anaesth 1991; 38: 430-435.
5. Robertson EN, Driessen JJ, Booij LHD. Pharmacokinetics and pharmacodynamics of rocuronium in patients with and without renal failure. Eur J Anaesthesiol 2005; 22: 4-10.
6. Flood P. The importance of myorelaxants in anesthesia. Curr Opin Pharmacol 2005; 5: 322-327.
7. Duvaldestin P, Saada J, Berger JL, D'Hollander A, Desmonts JM. Pharmacokinetics, pharmacodynamics, and dose-response relationships of pancuronium in control and elderly subjects. Anesthesiology 1982; 56: 36-40.
8. Lien CA, Matteo RS, Ornstein E, Schwartz AE, Diaz J. Distribution, elimination, and action of vecuronium in the elderly. Anesth Analg 1991; 73: 39-42.
9. McCarthy G, Elliott P, Mirakhur RK, Cooper R, Sharpe TD, Clarke RS. Onset and duration of action of vecuronium in the elderly: comparison with adults. Acta Anaesthesiol Scand 1992; 36: 383-386.
10. Matteo RS, Ornstein E, Schwartz AE, Ostapkovich N, Stone JG. Pharmacokinetics and pharmacodynamics of rocuronium (Org 9426) in elderly surgical patients. Anesth Analg 1993; 77: 1193-1197.
11. Bevan DR, Fiset P, Balendran P, Law-Min JC, Ratcliffe A, Donati F. Pharmacodynamic behaviour of rocuronium in the elderly. Can J Anaesth 1993; 40: 127-132.
12. Cope TM, Hunter JM. Selecting neuromuscular-blocking drugs for elderly patients. Drugs Aging 2003; 20: 125-140.
13. Bock M, Klippel K, Nitsche B, Bach A, Martin E, Motsch J. Rocuronium potency and recovery characteristics during steady-state desflurane, sevoflurane, isoflurane or propofol anaesthesia. Br J Anaesth 2000; 84: 43-47.
14. Dragne A, Varin F, Plaud B, Donati F. Rocuronium pharmacokinetic- pharmacodynamic relationship under stable propofol or isoflurane anesthesia. Can J Anaesth 2002; 49: 353-360.
15. Xue FS, Liao X, Tong SY, Liu JH, An G, Luo LK. Dose-response and time-course of the effect of rocuronium bromide during sevoflurane anaesthesia. Anaesthesia 1998; 53: 25-30.
16. Slavov V, Khalil M, Merle JC, Agostini MM, Ruggier R, Duvaldestin P. Comparison of duration of neuromuscular blocking effect of atracurium and vecuronium in young and elderly patients. Br J Anaesth 1995; 74: 709-711.
17. Duvaldestin P, Saada J, Berger JL, D'Hollander A, Desmonts JM. Pharmacokinetics, pharmacodynamics, and dose-response relationships of pancuronium in control and elderly subjects. Anesthesiology 1982; 56: 36-40.
18. Booij LHDJ. Neuromuscular transmission and its pharmacological blockade. Part 4: use of relaxants in paediatric and elderly patients, in obstetrics, and in the intensive care unit. Pharm World Sci 1997; 19: 45-52.
19. Frolkis VV, Martynenko OA, Zamostyan VP. Aging of the neuromuscular apparatus. Gerontology 1976; 22: 244-279.
20. de Almeida MC, Latorre F, Gervais HW, Kleeman PP. The effects of age on onset and recovery from atracurium, rocuronium and vecuronium blockade. Anaesthesist 1996; 45: 903-906.
21. Cooper RA, Maddineni VR, Mirakhur RK, Wierda JM, Brady M, Fitzpatrick KT. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide during isoflurane anaesthesia in patients with and without renal failure. Br J Anaesth 1993; 71: 222-226.
22. Khuenl-Brady KS, Pomaroli A, Pühringer F, Mitterschiffthaler G, Koller J. The use of rocuronium in patients with chronic renal failure. Anaesthesia 1993; 48: 873-875.
23. Cooper RA, Mirakhur RK, Wierda JM, Maddineni VR. Pharmacokinetics of rocuronium bromide in patients with and without renal failure. Eur J Anaesthesiol Suppl 1995; 11: 43-44.
24. Szenohradszky J, Caldwell JE, Sharma ML, Gruenke LD, Miller RD. Interaction of rocuronium (ORG 9426) and phenytoin in a patient undergoing cadaver renal transplantation: a possible pharmacokinetic mechanism? Anesthesiology 1994; 80: 1167-1170.
25. Loan PB, Connolly FM, Mirakhur RK, Kumar N, Farling P. Neuromuscular effects of rocuronium in patients receiving beta-adrenoreceptor blocking, calcium entry blocking and anticonvulsant drugs. Br J Anaesth 1997; 78: 90-91.
26. Rozen MS, Whan FM. Prolonged curarization associated with propranolol. Med J Aust 1972; 1: 467-468.
27. Kawabata K, Sumikawa K, Kamibayashi T et al. Decrease in vecuronium infusion dose requirements by nicardipine in humans. Anesth Analg 1994; 79: 1159-1164.
28. Jones RM, Cashman JN, Casson WR, Broadbent MP. Verapamil potentiation of neuromuscular blockade: failure of reversal with neostigmine but prompt reversal with edrophonium. Anesth Analg 1985; 65: 1021-1025.
29. Salvador A, del Pozo E, Carlos R, Baeyens JM. Differential effects of calcium channel blocking agents on pancuronium and suxamethonium induced neuromuscular blockade. Br J Anaesth 1988; 60: 495-499.
30. Viby-Mogensen J. Postoperative residual curarization and evidence-based anaesthesia. Br J Anaesth 2000; 84: 301-303.
31. Murphy GS, Szokol JW, Marymont JH, Franklin M, Avram MJ, Vender JS. Residual paralysis at the time of tracheal extubation. Anesth Analg 2005; 100: 1840-1845.